scPharmaceuticals Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.46 | -$0.41 | -$0.44 |
| Q2 2024 | 1 | -$0.44 | -$0.39 | -$0.42 |
| Q3 2024 | 1 | -$0.32 | -$0.28 | -$0.30 |
| Q4 2024 | 3 | -$0.47 | -$0.27 | -$0.34 |
| Q1 2025 | 2 | -$0.31 | -$0.27 | -$0.29 |
| Q2 2025 | 1 | -$0.27 | -$0.24 | -$0.26 |
| Q3 2025 | 1 | -$0.24 | -$0.21 | -$0.22 |
| Q4 2025 | 1 | -$0.16 | -$0.14 | -$0.15 |
scPharmaceuticals Inc. Earnings Date And Information
scPharmaceuticals Inc. last posted its earnings results on Wednesday, August 14th, 2024. The company reported $-0.44 earnings per share for the quarter, missing analysts' consensus estimates of $-0.44 by $0. The company had revenue of 10.03 M for the quarter and had revenue of 13.59 M for the year. scPharmaceuticals Inc. has generated $-1 earnings per share over the last year ($-1.42 diluted earnings per share) and currently has a price-to-earnings ratio of -1.95. scPharmaceuticals Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 11th, 2025 based on prior year's report dates.
scPharmaceuticals Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/13/2024 | Q3 2024 | -$0.75 | $10.81 M | $10.03 M | ||
| 08/14/2024 | Q2 2024 | -$0.44 | -$0.44 | 0 | $7.97 M | $8.05 M |
| 05/14/2024 | Q1 2024 | -$0.45 | -$0.36 | 0.09 | $6.10 M | |
| 03/13/2024 | Q4 2023 | -$0.42 | -$0.36 | 0.06 | $6.10 M | |
| 11/08/2023 | Q3 2023 | -$0.36 | -$0.40 | -0.04 | $3.40 M | $3.80 M |
| 08/10/2023 | Q2 2023 | -$0.37 | $1.45 M | $1.64 M | ||
| 05/10/2023 | Q1 2023 | -$0.36 | -$0.34 | 0.02 | $2.06 M | |
| 03/22/2023 | Q4 2022 | -$0.42 | -$0.31 | 0.11 | $0 | |
| 11/09/2022 | Q3 2022 | -$0.41 | -$0.38 | 0.03 | $0 | |
| 08/09/2022 | Q2 2022 | -$0.36 | $0 | |||
| 05/16/2022 | Q1 2022 | -$0.31 | -$0.30 | 0.01 | $0 | |
| 03/22/2022 | Q4 2021 | -$0.34 | -$0.27 | 0.07 | $0 | |
| 11/09/2021 | Q3 2021 | -$0.32 | -$0.24 | 0.08 | $0 | |
| 08/11/2021 | Q2 2021 | -$0.26 | $0 | |||
| 05/12/2021 | Q1 2021 | -$0.31 | -$0.26 | 0.05 | $0 | |
| 03/23/2021 | Q4 2020 | -$0.36 | -$0.28 | 0.08 | $0 | |
| 11/16/2020 | Q3 2020 | -$0.38 | -$0.33 | 0.05 | $0 | |
| 08/13/2020 | Q2 2020 | -$0.36 | $0 | |||
| 05/12/2020 | Q1 2020 | -$0.54 | -$0.35 | 0.19 | $0 | |
| 03/24/2020 | Q4 2019 | -$0.54 | -$0.58 | -0.04 | $0 |
scPharmaceuticals Inc. Earnings: Frequently Asked Questions
-
When is scPharmaceuticals Inc.'s earnings date?
scPharmaceuticals Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 11th, 2025 based off last year's report dates.
-
How can I listen to scPharmaceuticals Inc.'s earnings conference call?
The conference call for scPharmaceuticals Inc.'s latest earnings report can be listened to online.
-
How can I read scPharmaceuticals Inc.'s conference call transcript?
The conference call transcript for scPharmaceuticals Inc.'s latest earnings report can be read online.
-
How much revenue does scPharmaceuticals Inc. generate each year?
scPharmaceuticals Inc. (:SCPH) has a recorded annual revenue of $13.59 M.
-
How much profit does scPharmaceuticals Inc. generate each year?
scPharmaceuticals Inc. (:SCPH) has a recorded net income of $13.59 M. scPharmaceuticals Inc. has generated $-1.42 earnings per share over the last four quarters.
-
What is scPharmaceuticals Inc.'s price-to-earnings ratio?
scPharmaceuticals Inc. (:SCPH) has a price-to-earnings ratio of -1.95 and price/earnings-to-growth ratio is 0.09.
